作者
Letizia Canu,Janna A W Van Hemert,Michiel N. Kerstens,Robert P. Hartman,Aakanksha Khanna,Ivana Kraljević,Darko Kaštelan,Corin Badiu,Urszula Ambroziak,Antoine Tabarin,Magalie Haissaguerre,Edward Buitenwerf,Anneke Visser,Massimo Mannelli,Wiebke Arlt,Vasileios Chortis,Isabelle Bourdeau,Nadia Gagnon,Marie Buchy,Françoise Borson‐Chazot,Timo Deutschbein,Martin Faßnacht,Alicja Hubalewska‐Dydejczyk,Marcin Motyka,Ewelina Rzepka,Ruth Casey,Benjamin Challis,Marcus Quinkler,Laurent Vroonen,Ariadni Spyroglou,Felix Beuschlein,Cristina Lamas,William F. Young,Irina Bancos,Henri Timmers
摘要
Up to 7% of all adrenal incidentalomas (AIs) are pheochromocytomas (PCCs). In the evaluation of AI, it is generally recommended that PCC be excluded by measurement of plasma-free or 24-hour urinary fractionated metanephrines. However, recent studies suggest that biochemical exclusion of PCC not be performed for lesions with CT characteristics of an adrenocortical adenoma (ACA).